Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
Plos One|July 19, 2012
IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver diseaseAlessandra Biasiolo, Natascia Tono, Mariagrazia Ruvoletto, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 24, 2012
Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathySara Montagnese, Sami Schiff, Matteo Turco, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2005
The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascitesPaolo Angeli, Guillermo Fernández-Varo, Virna Dalla Libera, et al.Journal of Hepatology|May 14, 2013
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascitesSalvatore Piano, Silvia Rosi, Giulio Maresio, et al.Hepatology (Baltimore, Md.)|June 8, 2013
Sleep-wake abnormalities in patients with cirrhosisSara Montagnese, Cristiano De Pittà, Michele De Rui, et al.Frontiers in Neurology|January 8, 2015
The influence of environmental factors on sleep quality in hospitalized medical patientsMilena Bano, Federica Chiaromanni, Michela Corrias, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Prognostic benefit of the addition of a quantitative index of hepatic encephalopathy to the MELD score: the MELD-EEGSara Montagnese, Michele De Rui, Sami Schiff, et al.Metabolic Brain Disease|November 27, 2012
Excessive daytime sleepiness and hepatic encephalopathy: it is worth askingMichele De Rui, Sami Schiff, Daniele Aprile, et al.Experimental Biology and Medicine (Maywood, N.J.)|March 9, 2011
Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PDCristian Turato, Alessandra Biasiolo, Paolo Pengo, et al.Gastroenterology|August 10, 2004
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosisCarlo Merkel, Renato Marin, Paolo Angeli, et al.Pageof 10